Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Research Models: APP Mutations
APP Flemish/APP Dutch

General Information

Transgene: Human APP 770 cDNA

Mutation: Flemish A692G, Dutch E693Q

Promoter: Mouse thy-1 promoter

Mouse Strain: The constructs were microinjected into 1.5 day-old prenuclear embryos isolated from superovulated FVB/N females

In AD human patients:

--Dutch mutation causes HCHWA-D, characterized by extensive amyloid deposits in the small leptomenigeal and cortical arterioles, leads to premature death

--Flemish mutation causes a combined pathology of cerebral amyloid angiopathy (CAA) and presenile AD with the presence of both large-cored parenchymal senile plaques and extensive amyloid deposits in blood vessels.

Phenotype

Neuropathological Analysis:

Both APP/Fl and APP/Du transgenic mice significantly decrease a-secretase APP while increasing b-secretase cleaved C-terminal fragments, relative to wt APP transgene. (Mutations located near the a-secretase cleavage site favor b cleavage of APP. Increased processing of human APP at the b-secretase cleavage site causing increase formation of N-terminal fragments of Ab protein, which leads to amyloid plaque formation). 

Ab level in the APP/Fl and APP/Du mice remains low, without formation of amyloid plaque. In fact, these transgenic mice do not develop amyloid plaques or tau pathology, even by 22 months of age. 

Behavioral:

Behavioral, pharmacological and pathological observations disclose subtle aspects of early and late onset AD like APP/wt and APP/London, such as differential glutamatergic responses, increased aggression, occasional spontaneous seizures and variable premature death.

Availability

Licensing/academic distribution contact information:

Paul Van Dun
Director - KULeuvenR&D
Groot Begijnhof 59
B-3000 Leuven Belgium
tel +32 16 326508
fax +32 16 326515
Email: Paul.Vandun@lrd.kuleuven.ac.be
Web site: http://www.kuleuven.ac.be/lrd

Patents: None

Reference

Primary:

Kumar-Singh S, Dewachter I, Moechars D, Lubke U, De Jonghe C, Ceuterick C, Checler F, Naidu A, Cordell B, Cras P, Van Broeckhoven C, Van Leuven F.  Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation. Neurobiol Dis 2000 Feb;7(1):9-22. Abstract.

Associated:

Moechars D, Dewachter I, Lorent K, Reverse D, Baekelandt V, Naidu A, Tesseur I, Spittaels K, Haute CV, Checler F, Godaux E, Cordell B, Van Leuven F. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 1999 Mar 5;274(10):6483-92. Abstract.

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark

See recent updates
Alzheimer's Disease Mouse Model Resource
Considerations for Choosing Controls
Research Tools

Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad